Skip to main content
TipRanks
Go Ultimate75% OFF

Clinica Baviera (0GWJ) Ratios

0 Followers

Clinica Baviera Ratios

GB:0GWJ's free cash flow for Q2 2026 was €15.23M. For the 2026 fiscal year, GB:0GWJ's free cash flow was decreased by €-6.20M and operating cash flow was €18.97M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.960.951.281.091.08
Quick Ratio0.960.881.221.031.02
Cash Ratio0.090.200.180.470.28
Solvency Ratio0.480.540.610.540.53
Operating Cash Flow Ratio1.241.241.281.301.33
Short-Term Operating Cash Flow Coverage37.5831.1728.6926.6011.42
Net Current Asset Value€ -77.41M€ -65.61M€ -28.63M€ -37.13M€ -40.49M
Leverage Ratios
Debt-to-Assets Ratio0.280.300.270.320.39
Debt-to-Equity Ratio0.630.650.520.710.94
Debt-to-Capital Ratio0.390.400.340.420.49
Long-Term Debt-to-Capital Ratio0.050.070.010.040.11
Financial Leverage Ratio2.252.191.962.232.45
Debt Service Coverage Ratio20.6119.5820.9918.819.32
Interest Coverage Ratio36.0545.7587.4999.0786.03
Debt to Market Cap0.010.020.010.020.03
Interest Debt Per Share4.293.972.952.963.19
Net Debt to EBITDA0.600.680.580.510.78
Profitability Margins
Gross Profit Margin42.11%88.36%87.96%87.15%87.56%
EBIT Margin27.25%21.78%22.33%20.71%22.81%
EBITDA Margin35.17%29.74%29.89%28.30%30.97%
Operating Profit Margin27.25%21.20%22.24%20.91%22.83%
Pretax Profit Margin19.92%21.32%22.08%20.50%22.52%
Net Profit Margin13.94%15.31%15.99%14.87%15.86%
Continuous Operations Profit Margin14.23%15.67%16.33%15.22%16.17%
Net Income Per EBT69.97%71.81%72.44%72.56%70.41%
EBT Per EBIT73.10%100.57%99.28%98.04%98.66%
Return on Assets (ROA)16.99%18.97%20.14%19.67%20.47%
Return on Equity (ROE)38.24%41.48%39.53%43.83%50.16%
Return on Capital Employed (ROCE)44.20%34.53%37.50%38.04%39.99%
Return on Invested Capital (ROIC)29.49%23.70%25.69%25.86%25.70%
Return on Tangible Assets20.28%22.99%22.30%21.86%23.17%
Earnings Yield5.09%7.92%9.61%10.38%7.92%
Efficiency Ratios
Receivables Turnover63.7954.5563.1569.7851.36
Payables Turnover6.903.041.741.631.66
Inventory Turnover0.009.3110.9511.8011.11
Fixed Asset Turnover2.122.142.272.312.24
Asset Turnover1.221.241.261.321.29
Working Capital Turnover Ratio-119.6153.8428.0463.29199.59
Cash Conversion Cycle-47.16-74.26-170.17-187.43-180.59
Days of Sales Outstanding5.726.695.785.237.11
Days of Inventory Outstanding0.0039.2033.3530.9432.84
Days of Payables Outstanding52.88120.16209.29223.59220.54
Operating Cycle5.7245.9039.1336.1739.95
Cash Flow Ratios
Operating Cash Flow Per Share4.603.863.553.272.87
Free Cash Flow Per Share2.792.232.162.412.23
Dividend Paid and CapEx Coverage Ratio1.361.201.621.711.68
Capital Expenditure Coverage Ratio2.552.372.553.804.43
Operating Cash Flow Coverage Ratio1.110.991.221.120.91
Operating Cash Flow to Sales Ratio0.250.240.260.270.27
Free Cash Flow Yield5.62%7.14%9.39%13.83%10.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio18.9012.6310.419.6412.62
Price-to-Sales (P/S) Ratio2.741.931.661.432.00
Price-to-Book (P/B) Ratio7.525.244.114.226.33
Price-to-Free Cash Flow (P/FCF) Ratio17.8014.0110.667.239.53
Price-to-Operating Cash Flow Ratio10.818.096.485.337.38
Price-to-Earnings Growth (PEG) Ratio2.921.070.471.250.13
Enterprise Value Multiple8.397.186.155.587.24
Enterprise Value890.73M561.18M413.47M313.13M387.38M
EV to EBITDA8.397.186.155.587.24
EV to Sales2.952.141.841.582.24
EV to Free Cash Flow19.1715.4811.777.9610.68
EV to Operating Cash Flow11.658.947.155.878.27
Tangible Book Value Per Share4.263.774.603.272.44
Shareholders’ Equity Per Share6.615.955.594.133.35
Tax and Other Ratios
Effective Tax Rate0.290.270.260.260.28
Revenue Per Share18.1316.1413.8212.1710.59
Net Income Per Share2.532.472.211.811.68
Tax Burden0.700.720.720.730.70
Interest Burden0.730.980.990.990.99
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.130.140.070.090.09
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.781.121.611.311.20

Currency in EUR